CoChat

Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Crossover Trial

Phillips, Craig L., Yee, Brendon J., Marshall, Nathaniel S., Liu, Peter Y., Sullivan, David R., Grunstein, Ronald R. · 2011 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Rationale: Dyslipidemia is common in Obstructive Sleep Apnea (OSA). Postprandial lipidemia (PPL) is a strong marker of cardiovascular risk. Evidence that OSA treatment improves PPL is lacking. Objectives: To investigate the effect of continuous positive airway pressure (CPAP) treatment on postprandial lipidemia (PPL) in patients with obstructive sleep apnea (OSA) in the upper moderate or severe range. Methods: In this randomized, placebo-controlled crossover trial, we compared the effects of 2 months each of therapeutic and placebo CPAP on PPL. Measurements and Main Results: PPL was determined from the area under the 24-hour triglyceride concentration curve (TAG-AUC24) using seven blood samples drawn across both the wake and sleep periods. Secondary outcomes were the difference in other 24-hour lipid profiles. Thirty-eight eligible patients were randomly assigned to a treatment order and 29 patients completed the trial. CPAP reduced PPL compared with placebo with a mean TAG-AUC24 difference of −357 mmol/L/d (95% confidence interval [CI], −687.3 to −26.8; P = 0.035). During both the CPAP and placebo studies, TAG levels peaked during both wakefulness (2:00 p.m.) and sleep (3:00 a.m.). Both peaks were lower during CPAP than placebo: 2:00 p.m., −0.49 mmol/L (95% CI, −0.74 to −0.24; P < 0.0005) and 3:00 a.m., −0.40 mmol/L (95% CI, −0.65 to −0.15; P = 0.002). Moreover, mean 24-hour total cholesterol was −0.19 mmol/L lower on CPAP (95% CI, −0.27 to −0.11; P < 0.00001). Conclusions: This randomized trial demonstrated that treatment of severe OSA with CPAP improves postprandial TAG and total cholesterol levels. These effects may reduce the risk for cardiovascular events. The results imply that the association between OSA and cardiovascular disease may, in part, be caused by direct effects on dyslipidemia. Clinical trial registered with the Australian and New Zealand Clinical Trials Registry at www.anzctr.org.au (ACTRN 12605000066684).

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201102-0316oc

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 2

  1. Phillips, 2010, Treatment of obstructive sleep apnoea reduces post-prandial lipidemia: evidence from a randomized, placebo-controlled trial of continuous positive airway pressure [abstract], J Sleep Res, 19, 513
  2. Phillips, 2010, Treatment of obstructive sleep apnea (OSA) with nasal continuous positive airway pressure (CPAP) reduces postprandial lipidemia (PPL). A randomised placebo-controlled crossover study [abstract], Sleep Biol Rhythms, 8, A18

Cited by

See all 145

Metadata

Authors
Phillips, C. L., Yee, B. J., Marshall, N. S., Liu, P. Y., Sullivan, D. R., & Grunstein, R. R.
Affiliations
  • The University of Sydney (AU)
  • Royal Prince Alfred Hospital (AU)
Corresponding author
Phillips, Craig L.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2011-08-01
Volume
184
Issue
3
Pages
355-361
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1955906838
Cited by
145
References
40
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 17 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 14 · 2017: 7 · 2016: 12 · 2015: 15 · 2014: 13 · 2013: 10 · 2012: 21
FWCI
10.10
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Keywords
continuous positive airway pressure, obstructive sleep apnea, postprandial lipemia, triglycerides, dyslipidemia, total cholesterol, cardiovascular risk, sleep-disordered breathing, lipid profile
MeSH terms
Cardiovascular Diseases, Female, Humans, Male, Middle Aged, New South Wales, Triglycerides, Cross-Over Studies, Postprandial Period, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Dyslipidemias, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Crossover Trial. https://app.cochat.ai/papers/10.1164/rccm.201102-0316oc
The paper
Phillips, C. L., Yee, B. J., Marshall, N. S., Liu, P. Y., Sullivan, D. R., & Grunstein, R. R. (2011). Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Crossover Trial. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201102-0316oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.